Cambridge Cognition Holdings PLC (COG) Rating Reiterated by FinnCap
Cambridge Cognition Holdings PLC (LON:COG)‘s stock had its “corporate” rating reissued by equities researchers at FinnCap in a research report issued on Thursday. They currently have a GBX 130 ($1.69) target price on the stock. FinnCap’s price objective would indicate a potential upside of 7.00% from the company’s current price.
Shares of Cambridge Cognition Holdings PLC (LON:COG) remained flat at GBX 121.50 on Thursday. The company’s stock had a trading volume of 35,206 shares. Cambridge Cognition Holdings PLC has a 12-month low of GBX 55.00 and a 12-month high of GBX 132.00. The firm’s 50 day moving average is GBX 118.90 and its 200-day moving average is GBX 104.27. The stock’s market cap is GBX 24.87 million.
In other Cambridge Cognition Holdings PLC news, insider Andrew Damian Blackwell sold 131,095 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of GBX 109 ($1.42), for a total transaction of £142,893.55 ($185,503.76).
Cambridge Cognition Holdings PLC Company Profile
Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company’s segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials.
Receive News & Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related companies with MarketBeat.com's FREE daily email newsletter.